Skip to main content
Sign In
 

Deborah Gilbert, RN, CPNP

Nurse Practitioner


Deborah Gilbert, RN, CPNP
Contact:

Department of Pediatric Otolaryngology
Children’s Hospital Colorado
13123 East 16th Avenue, Mail Stop B455
Aurora, CO 80045

Phone: 720-777-8501
Fax: 303-724-1961
Email:  Deborah.Gilbert@childrenscolorado.org


Hospital Affiliations:

Children's Hospital Colorado

  • MS, Pediatric Nurse Practitioner, University of Colorado Denver Health Sciences Center 
  • BS, Nursing, University of Kansas Medical Center
  • ​​Boucek, M.M., Sondheimer, H.M., Ivy, D.D., Shaffer, E.M, Mashburn, C., Ripe, D.W., Gilbert, D.J., Kyle, T.E., Campbell, D.N., Pietra, B. (2001). Transplant coronary artery disease in pediatrics: favorable outcome with medical therapy. The Journal of Heart and Lung Transplantation, 20(2), 261.
  • Miyamoto, S., Gilbert, D., Ballard, A., Anderson, S., Le, P., Mitchell, M., Campbell, D., Pietra, B. (2007). Ccampath-1H therapy for resistant rejection in pediatric heart transplant patients. The Journal of Heart and Lung Transplantation, 26(2), S246-S247.
  • Pietra, B., Ivy, D.D., Sondheimer, H.M., Shaffer, E.M., Mashburn, C., Ripe, D.W., Gilbert, D.J., Kyle, T.E., Mitchell, M.B,, Campbell, D.N., Boucek, M.M. (2001). Comparison of pretransplant transfusion with  our  without cyclosporin inhibition on post transplant outcome. The Journal of Heart and Lung Transplantation, 20(2), 222-223.
  • Tissot, C., Pietra, B., Boucek, M., Gilbert, D., Campbell, D., Mitchell, M., Miyamoto, S. (2008). Coronary Flow Reserve Differentiates Stables from Progressive Transplant Coronary Artery Disease in Pediatric Heart Recipients. The Journal of Heart and Lung Transplantation, 27(2), S128-S128.
  • Gilbert D, Auerbach, SR, Campbell, DN, Mitchell, MB, Jaggers J, Pietra BA, Miyamoto SD (2011) Infant Waitlist Mortality is Unchanged in the Norwood Era (abstract). Poster presented at IPTA conference in June 2011.
  • Darst JR, Gilbert D, Connell, C, Kloote J, Pietra B, Miyamoto, S. Successful treatment of resistant rejection with alemtuzumab in pediatric heart transplant patients. In progress. To be submitted. Presented at Advances in Organ Transplantation, Boston, MA 2008 *Abstract only, no manuscript yet. 
  • Contributed a chapter titled “Nursing considerations for the pediatric heart transplant patient” to the textbook Pediatric Cardiology, Cardiac Surgery, and Intensive Care, Eduardo M. da Cruz, D. Dunbar Ivy, Viktor Hraska, James Jaggers (Eds.) 2012.
  • American Academy of Otolaryngology-Head and Neck Surgery 
  • National Association of Pediatric Nurse Practitioners (NAPNAP)